|
Secondary prevention
Citations 461-470 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Risk of Myocardial Infarction and Angina in
Patients With Severe Peripheral Vascular
Disease. Predictive Role of C-Reactive
Protein
- Elisabetta Rossi, Luigi M. Biasucci, Franco Citterio, Simona Pelliccioni, Claudia Monaco, Francesca Ginnetti, Dominick J. Angiolillo, Gianni Grieco, Giovanna Liuzzo, and Attilio Maseri
Circulation published January 22, 2002, doi:10.1161/hc0702.104126
[Abstract]
- Brief Rapid Communications
Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
- Mohamad Navab, G.M. Anantharamaiah, Susan Hama, David W. Garber, Manjula Chaddha, Greg Hough, Roger Lallone, and Alan M. Fogelman
Circulation 2002;105:290-292, doi:10.1161/hc0302.103711
[Abstract]
[Full text]
- Clinical Investigations and Reports
Coronary Collateral Size, Flow Capacity, and Growth: Estimates From the Angiogram in Patients With Obstructive Coronary Disease
- Julia Rockstroh and B. Greg Brown
Circulation 2002;105:168-173, doi:10.1161/hc0202.102120
[Abstract]
[Full text]
- Articles
Early and Sustained Survival Benefit Associated
With Statin Therapy at the Time of Percutaneous
Coronary Intervention
- Albert W. Chan, Deepak L. Bhatt, Derek P. Chew, Martin J. Quinn, David J. Moliterno, Eric J. Topol, and Stephen G. Ellis
Circulation published December 31, 2001, doi:10.1161/hc0602.103586
[Abstract]
- Clinical Investigations and Reports
Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S
- Christie M. Ballantyne, Anders G. Olsson, Thomas J. Cook, Michele F. Mercuri, Terje R. Pedersen, and John Kjekshus
Circulation 2001;104:3046-3051, doi:10.1161/hc5001.100624
[Abstract]
[Full text]
- Correspondence
Does Tamoxifen Enhance Endothelial Function by Lowering the Plasma Levels of Homocysteine? • Effects of Tamoxifen on Endothelial Function and Cardiovascular Risk Factors in Men With Advanced Atherosclerosis • Effects of Tamoxifen on Endothelial Function and Cardiovascular Risk Factors in Men With Advanced Atherosclerosis • Response
- Marco Cattaneo, Dimitrios N. Kiortsis, Moses S. Elisaf, K.M. English, P.J. Pugh, K.S. Channer, Sarah C. Clarke, Peter M. Schofield, Andrew A. Grace, James C. Metcalfe, and Heide L. Kirschenlohr
Circulation 2001;104:e146-147e
[Full text]
- Clinical Investigations and Reports
Comparison of Use of Medications After Acute Myocardial Infarction in the Veterans Health Administration and Medicare
- Laura A. Petersen, Sharon-Lise T. Normand, Lucian L. Leape, and Barbara J. McNeil
Circulation 2001;104:2898-2904, doi:10.1161/hc4901.100524
[Abstract]
[Full text]
- Correspondence
High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease
- Carlos Guijarro
Circulation 2001;104:e127
[Full text]
- Clinical Investigations and Reports
Effect of an Aggressive Lipid-Lowering Strategy on Progression of Atherosclerosis in the Left Main Coronary Artery From Patients in the Post Coronary Artery Bypass Graft Trial
- Carl W. White, Fredarick L. Gobel, Lucien Campeau, Genell L. Knatterud, Sandra A. Forman, James S. Forrester, Nancy L. Geller, J. Alan Herd, Ann Hickey, Byron J. Hoogwerf, Donald B. Hunninghake, Yves Rosenberg, and Michael L. Terrin
Circulation 2001;104:2660-2665, doi:10.1161/hc4701.099730
[Abstract]
[Full text]
- Correspondence
Increased Mortality With Long-Term Platelet Glycoprotein IIb/IIIa Antagonists: An Explanation? • Response
- Jos Vermylen, Marc Hoylaerts, Jef Arnout, Derek P. Chew, Deepak L. Bhatt, Eric J. Topol, and Shelly Sapp
Circulation 2001;104:e109
[Full text]
|
|
